(CFA) VictoryShares US 500 - Overview
Etf: Large Cap Stocks, Volatility Weighted, US Equity
Dividends
| Dividend Yield | 1.37% |
| Yield on Cost 5y | 1.89% |
| Yield CAGR 5y | 9.83% |
| Payout Consistency | 99.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 10.9% |
| Relative Tail Risk | 0.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.42 |
| Alpha | -2.96 |
| Character TTM | |
|---|---|
| Beta | 0.764 |
| Beta Downside | 0.788 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.28% |
| CAGR/Max DD | 0.71 |
Description: CFA VictoryShares US 500 January 25, 2026
The VictoryShares US 500 Volatility-Weighted ETF (NASDAQ:CFA) aims to track at least 80% of its assets to the Nasdaq Victory U.S. Large-Cap 500 Volatility-Weighted Index, an unmanaged index that selects the 500 biggest U.S. equities by market cap and re-weights them according to each stock’s recent price volatility. By emphasizing volatility, the fund seeks to tilt toward stocks that have exhibited higher price swings, potentially offering a different risk-return profile than a traditional cap-weighted S&P 500 replica.
As of the latest filing (January 2026):
• Expense ratio ≈ 0.35%, below the average 0.45% for large-blend ETFs.
• Assets under management ≈ $1.2 billion, reflecting a modest inflow of ~5% YoY despite a 12-month total return of –2.3% versus the S&P 500’s +4.1% (both figures net of fees).
• Sector exposure is heavily skewed to technology (≈ 45% of net assets) and health care (≈ 18%), sectors that have driven the index’s volatility premium amid ongoing Fed policy tightening and elevated corporate earnings revisions.
These metrics suggest the ETF’s performance is closely tied to macro-level drivers such as interest-rate expectations and the earnings momentum of high-growth tech firms.
For a deeper, data-rich view of CFA’s risk-adjusted characteristics, you might explore the ValueRay platform’s interactive analytics.
What is the price of CFA shares?
Over the past week, the price has changed by +2.35%, over one month by +2.80%, over three months by +8.09% and over the past year by +10.08%.
Is CFA a buy, sell or hold?
What are the forecasts/targets for the CFA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 106.4 | 11% |
CFA Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 534.7m USD (534.7m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 534.7m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 534.7m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.73% (E(534.7m)/V(534.7m) * Re(8.73%) + (debt-free company))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)